268 related articles for article (PubMed ID: 7535432)
41. Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems.
de Wynter EA; Coutinho LH; Pei X; Marsh JC; Hows J; Luft T; Testa NG
Stem Cells; 1995 Sep; 13(5):524-32. PubMed ID: 8528102
[TBL] [Abstract][Full Text] [Related]
42. A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells.
da Silva CL; Gonçalves R; Crapnell KB; Cabral JM; Zanjani ED; Almeida-Porada G
Exp Hematol; 2005 Jul; 33(7):828-35. PubMed ID: 15963859
[TBL] [Abstract][Full Text] [Related]
43. An improved panning technique for the selection of CD34+ human bone marrow hematopoietic cells with high recovery of early progenitors.
Cardoso AA; Watt SM; Batard P; Li ML; Hatzfeld A; Genevier H; Hatzfeld J
Exp Hematol; 1995 May; 23(5):407-12. PubMed ID: 7536682
[TBL] [Abstract][Full Text] [Related]
44. Stem cell selection--clinical experience.
Berenson RJ; Bensinger WI; Hill R; Andrews RG; Garcia-Lopez J; Kalamasz DF; Still BJ; Buckner CD; Bernstein ID; Thomas ED
Prog Clin Biol Res; 1990; 333():403-10; discussion 411-3. PubMed ID: 1689855
[TBL] [Abstract][Full Text] [Related]
45. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
46. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation.
Payne TA; Traycoff CM; Laver J; Xu F; Srour EF; Abboud MR
Bone Marrow Transplant; 1995 Feb; 15(2):187-92. PubMed ID: 7539665
[TBL] [Abstract][Full Text] [Related]
47. Expansion of HPCs from cord blood in a novel 3D matrix.
Ehring B; Biber K; Upton TM; Plosky D; Pykett M; Rosenzweig M
Cytotherapy; 2003; 5(6):490-9. PubMed ID: 14660045
[TBL] [Abstract][Full Text] [Related]
48. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
49. Flow cytometric quantitation of circulating hematopoietic progenitor cells in breast cancer patients on chemotherapy.
Read EJ; O'Shaughnessy JA; Yu MY; Cottler-Fox M; Denicoff AM; Cowan KH; Gress RE
Prog Clin Biol Res; 1992; 377():523-30. PubMed ID: 1279720
[No Abstract] [Full Text] [Related]
50. Suitability of neonatal vertebral body marrow for transplant applications.
Kong SS; Selvaggi G; Kenyon N; Knapp J; Olson L; Tzakis AG; Miller J; Ricordi C
Transplant Proc; 1995 Dec; 27(6):3416. PubMed ID: 8540028
[No Abstract] [Full Text] [Related]
51. CD34+ and CD33+ stem cells: predictors of hematologic recovery?
Ross RE; Jeter EK; Stuart RK; Self SE; Lavia MF
Prog Clin Biol Res; 1992; 377():505-12. PubMed ID: 1279718
[No Abstract] [Full Text] [Related]
52. Positive selection of CD34+ hematopoietic progenitor cells for transplantation.
Shpall EJ; Jones RB; Bearman SI; Stemmer SM; Purdy MH; Heimfeld S; Berenson RJ
Stem Cells; 1993 Oct; 11 Suppl 3():48-9. PubMed ID: 7507756
[No Abstract] [Full Text] [Related]
53. Characterization of CD34+ cells mobilized to the peripheral blood during the recovery from cyclophosphamide chemotherapy.
Bender JG; Unverzagt KL; Walker DE; Lee W; Lum L; Van Epps DE; Williams SF; To LB
Prog Clin Biol Res; 1992; 377():575-82. PubMed ID: 1279727
[No Abstract] [Full Text] [Related]
54. Cytokine effect on ex vivo expansion of haemopoietic stem cells from different human sources.
Eridani S; Mazza U; Massaro P; La Targia ML; Maiolo AT; Mosca A
Biotherapy; 1998; 11(4):291-6. PubMed ID: 9950105
[TBL] [Abstract][Full Text] [Related]
55. CD34+ selected cells in clinical transplantation.
Collins RH
Stem Cells; 1994 Nov; 12(6):577-85. PubMed ID: 7533577
[TBL] [Abstract][Full Text] [Related]
56. The AIS CELLector: a new technology for stem cell purification.
Okarma T; Lebkowski J; Schain L; Harvey M; Tricot G; Srour E; Meyers WG; Burnett A; Sniecinski I; O'Reilly RJ
Prog Clin Biol Res; 1992; 377():487-502; discussion 503-4. PubMed ID: 1279717
[No Abstract] [Full Text] [Related]
57. The effect of in vivo administration of recombinant methionyl human stem cell factor on the number of human marrow hematopoietic stem cells.
Tong J; Gordon MS; Srour EF; Cooper RJ; Orazi A; McNiece I; Hoffman R
Trans Assoc Am Physicians; 1993; 106():134-44. PubMed ID: 7518622
[No Abstract] [Full Text] [Related]
58. Hemopoietic stem cell characterization.
Lansdorp PM; Schmitt C; Sutherland HJ; Craig WH; Dragowska W; Thomas TE; Eaves CJ
Prog Clin Biol Res; 1992; 377():475-84; discussion 485-6. PubMed ID: 1279716
[No Abstract] [Full Text] [Related]
59. [CD34+ cells in the autotransplant of bone marrow and peripheral blood].
Silvestri F; Baccarani M
Recenti Prog Med; 1992 Feb; 83(2):89-92. PubMed ID: 1380174
[TBL] [Abstract][Full Text] [Related]
60. [Flow cytometry identification of CD34-positive cells].
Tichelli A; Kralj A; Huxol H; Schönenberger A; Rabaglio M; Borel J; Müller R; Bargetzi M; Gratwohl A; Signer E
Schweiz Med Wochenschr; 1995 Mar; 125(9):400-4. PubMed ID: 7534431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
